文献速递瓣膜外科先天性心脏病外科

儿童单叶式主动脉瓣二瓣化修复经验

Unicuspid aortic valve repair with bicuspidization in the paediatric population.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

本研究回顾了2003至2018年间60例≤18岁单叶式主动脉瓣患者行二瓣化修复的经验,中位手术年龄13岁。10年总体生存率96%,5年和10年免于主动脉瓣再手术率分别为73%和50%,25%患者最终需瓣膜置换。二瓣化修复安全可重复,可作为瓣膜置换的过渡。

要点

  • 二瓣化修复在儿童单叶式主动脉瓣中安全可重复,10年生存率96%。
  • 5年和10年免于再手术率分别为73%和50%,再手术常见原因为补片退变。
  • 25%患者最终需瓣膜置换,中位间隔5.2年,可作为过渡策略。

核心结论

  • 二瓣化修复是儿童单叶式主动脉瓣替代瓣膜置换的安全可重复选择,免于再手术率可接受,可作为瓣膜置换的过渡。

研究设计与样本

  • 回顾性队列研究,纳入2003至2018年间≤18岁行二瓣化修复的单叶式主动脉瓣患者60例,中位手术年龄13岁(范围1-18岁)。

主要发现

  • 围术期无中转瓣膜置换;10年总体生存率96%,有2例晚期死亡。
  • 20例因补片退变(11例)、补片缝线开裂(3例)、主动脉瓣下狭窄(3例)或其他原因(3例)行主动脉瓣再手术。
  • 5年和10年免于主动脉瓣再手术率分别为73%和50%。

关键数值与推荐

  • 补片材料:初期使用自体心包(45例),2014年后使用去细胞异种组织(11例)或膨体聚四氟乙烯膜(4例)。

临床怎么用

  • 对于儿童单叶式主动脉瓣,二瓣化修复可作为瓣膜置换的过渡策略,需告知再手术风险及最终可能需瓣膜置换。

局限性

  • 回顾性单中心研究,样本量有限,补片材料随时间变化,缺乏对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Aortic stenosis or regurgitation that requires operations in children often results from unicuspid valve morphology. In all paediatric patients with this anomaly, we have performed unicuspid valve repair by bicuspidization, creating a new commissure via adding patch material. This study reviewed our experience with this procedure. METHODS: All patients with a unicuspid aortic valve who underwent bicuspidization at ≤18 years of age between 2003 and 2018 were evaluated. Autologous pericardium had initially been used for cusp augmentation. Since 2014, decellularized xenogeneic tissue or expanded polytetrafluoroethylene membrane has been applied. RESULTS: There were 60 consecutive patients. The median operative age was 13 (1-18) years. Thirty patients had prior surgical or catheter valvuloplasties. Aortic regurgitation, aortic stenosis and their combination were present in 22, 11 and 27 patients, respectively. Autologous pericardium decellularized tissue and expanded polytetrafluoroethylene were used in 45, 11 and 4 patients, respectively, without intraoperative conversion to valve replacement. The overall survival was 96% at 10 years with 2 late deaths. Twenty patients underwent aortic valve reoperation due to patch degeneration (n = 11), suture dehiscence of the patch (n = 3), subaortic stenosis (n = 3) or other reasons (n = 3). Freedom from aortic valve reoperation was 73% and 50% at 5 and 10 years, respectively. Fifteen patients (25%) required valve replacement with pulmonary autograft (n = 14) or prosthesis (n = 1) 5.2 (0.2-13) years after bicuspidization at the age of 19 (10-32) years. CONCLUSIONS: Bicuspidization is a safe and reproducible alternative to valve replacement with acceptable freedom from reoperation. It can serve as a bridge to valve replacement providing superior outcomes in adults.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Matsushima S, Heß A, Lämmerzahl JR, et al. Unicuspid aortic valve repair with bicuspidization in the paediatric population. Eur J Cardiothorac Surg. 2021. PMID: 33001166. doi:10.1093/ejcts/ezaa285

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。